Scaling the healthcare wall: is Mexico an attractive market for high cost drug makers?

By Jack Rawson, Analyst Email: jrawson@partners4access.com At first glance Mexico presents a significant opportunity for drug manufacturers, with a large population of over 126 million, a developing economy and universal access to reimbursed healthcare. The aging population is also placing an increased need for healthcare services and statistics on the demand for drugs are favourable.…